Growth hormone, obesity can trigger sleep apnea in some kids

January 18, 2006

Growth hormone helps hundreds of children with a rare disorder that causes them to gorge on food, but for some, starting treatment can worsen a dangerous nighttime breathing problem, University of Florida researchers have found.

Sleep apnea disrupts breathing during sleep and is common among morbidly obese children, including those with Prader-Willi syndrome, a disease that compels them to eat nonstop. Researchers say that uncovering how to treat obesity and related problems in children genetically wired to be overweight could help them better battle childhood obesity in general.

Growth hormone has shown to be one of the most effective ways to treat children and adults with Prader-Willi. But UF researchers found that starting treatments can worsen or trigger sleep apnea in obese children exposed to colds, potentially leading to death, according to findings published online recently in The Journal of Clinical Endocrinology and Metabolism.

"Every kid we studied had abnormal sleep at the beginning, before growth hormone," said Jennifer Miller, M.D., a UF assistant professor of pediatrics and the study's lead author. "On growth hormone, most of them got better but not all of them. The ones that got worse tended to be school age. Some of them were just entering school and then they were coming home with upper-respiratory infections.

"The combination of starting growth hormone, still having weak muscle tone, having an illness and/or being obese tends to put you at risk for having really bad obstructive sleep apnea."

The researchers urge doctors to monitor patients' sleep before and during treatment for signs of obstructive sleep apnea, such as loud snoring or abnormal daytime sleepiness. Sleep studies are recommended for all obese children, not just those with Prader-Willi, Miller added.

Prader-Willi syndrome is caused by a rare chromosomal defect and occurs in only one of every 12,000 to 15,000 people, according to the Prader-Willi Syndrome Association. Children and adults with the disease have mental impairment, poor muscle tone and appetites so insatiable their parents often have to lock up food. Many patients become morbidly obese.

Overall, about 9 million children in the United States are overweight or obese. That's about three times as many as in 1980, and the causes vary, according to the Centers for Disease Control and Prevention.

"Prader-Willi syndrome highlights the major problem of obesity - it's more than just overeating," said Bryan E. Hainline, M.D., Ph.D., an Indiana University associate professor of pediatrics who specializes in pediatric metabolism and genetics. "There are genes that control it and other physiological factors that impair health."

Obesity also can lead to severe respiratory problems as fat accumulates in the upper body and throat, and these effects cause the most problems for obese patients, including those with Prader-Willi, Hainline said. The UF study highlights this, he added.

Growth hormone was approved in the United States to treat Prader-Willi in 2000, but several children with the disease died after beginning the treatments. All died in their sleep and had been battling infections. To understand the problem, UF researchers decided to study how growth hormone affected sleep, monitoring patients on the therapy closely and performing sleep studies before and during treatment, Miller said.

The researchers studied 25 children and adults with Prader-Willi syndrome, a large sample for such a rare disorder. Four school-age children had increased difficulty breathing at night shortly after the treatment began. All began having problems after they were exposed to upper respiratory infections in school, the findings show.

The children's muscles were so weak at the beginning of the treatment they couldn't breathe with a stuffed-up nose, Miller said. Growth hormone worsened the problem, causing the tonsils to swell and exacerbating their sleep apnea.

"We realized it was an infection issue," Miller said. "They didn't have the strength to overcome any resistance."

To keep patients safe, the researchers suggest doctors perform sleep studies on children before and during treatment. Some children may also need to have their tonsils removed if necessary. This helps, but because of their poor muscle tone and obesity, Prader-Willi patients have more risks to anesthesia, Miller said.

"The important part is for parents to realize that being on growth hormone, while it's good for most people, there is a subset that's vulnerable to having problems during sleep," she said. "That's why the sleep study should be done, because we don't know who it's going to be."
-end-


University of Florida

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.